IBM QRadar Suite Software/Cloud Pak for Security Case Management Script Creation code injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.0 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in IBM QRadar Suite Software and Cloud Pak for Security. This vulnerability affects unknown code of the component Case Management Script Creation. Executing a manipulation can lead to code injection. The identification of this vulnerability is CVE-2025-25021. The attack may be launched remotely. There is no exploit available. You should upgrade the affected component.
Details
A vulnerability was found in IBM QRadar Suite Software and Cloud Pak for Security (affected version not known). It has been declared as critical. This vulnerability affects some unknown functionality of the component Case Management Script Creation. The manipulation with an unknown input leads to a code injection vulnerability. The CWE definition for the vulnerability is CWE-94. The product constructs all or part of a code segment using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the syntax or behavior of the intended code segment. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
IBM QRadar Suite Software 1.10.12.0 through 1.11.2.0 and IBM Cloud Pak for Security 1.10.0.0 through 1.10.11.0 could allow a privileged execute code in case management script creation due to the improper generation of code.
The weakness was shared by Dawid Bak. The advisory is shared for download at ibm.com. This vulnerability was named CVE-2025-25021 since 01/31/2025. The exploitation appears to be easy. The attack can be initiated remotely. Additional levels of successful authentication are needed for exploitation. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 08/13/2025). The MITRE ATT&CK project declares the attack technique as T1059.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-16759). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.2VulDB Meta Temp Score: 7.1
VulDB Base Score: 7.2
VulDB Temp Score: 6.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 7.2
CNA Vector (ibm): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Code injectionCWE: CWE-94 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
01/31/2025 🔍06/03/2025 🔍
06/03/2025 🔍
08/13/2025 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Researcher: Dawid Bak
Status: Confirmed
CVE: CVE-2025-25021 (🔍)
GCVE (CVE): GCVE-0-2025-25021
GCVE (VulDB): GCVE-100-310984
EUVD: 🔍
Entry
Created: 06/03/2025 17:59Updated: 08/13/2025 07:03
Changes: 06/03/2025 17:59 (65), 06/04/2025 07:17 (1), 08/13/2025 07:03 (1)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.